Aridis Pharmaceuticals Inc.Aridis Pharmaceuticals Inc.Aridis Pharmaceuticals Inc.

Aridis Pharmaceuticals Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪2.67 M‬USD
−0.1522USD
‪−30.37 M‬USD
‪3.09 M‬USD
‪37.07 M‬
Beta (1Y)
−0.16

About Aridis Pharmaceuticals Inc.

CEO
Vu L. Truong
Headquarters
Los Gatos
Employees (FY)
37
Founded
2003
FIGI
BBG00LGF35J7
Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using human monoclonal antibodies, or mAbs, to treat infections. The company was founded by Eric J. Patzer and Vu L. Truong on April 24, 2003 and is headquartered in Los Gatos, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ARDS is 0.0600 USD — it has increased by 3.27% in the past 24 hours. Watch Aridis Pharmaceuticals Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Aridis Pharmaceuticals Inc. stocks are traded under the ticker ARDS.
ARDS stock has fallen by 7.83% compared to the previous week, the last month showed zero change in price, over the last year Aridis Pharmaceuticals Inc. has showed a 77.19% decrease.
ARDS reached its all-time high on Aug 30, 2018 with the price of 13.8500 USD, and its all-time low was 0.0500 USD and was reached on Oct 17, 2023. View more price dynamics on ARDS chart.
See other stocks reaching their highest and lowest prices.
ARDS stock is 22.20% volatile and has beta coefficient of −0.16. Track Aridis Pharmaceuticals Inc. stock price on the chart and check out the list of the most volatile stocks — is Aridis Pharmaceuticals Inc. there?
Today Aridis Pharmaceuticals Inc. has the market capitalization of ‪2.67 M‬, it has increased by 18.64% over the last week.
Yes, you can track Aridis Pharmaceuticals Inc. financials in yearly and quarterly reports right on TradingView.
Aridis Pharmaceuticals Inc. is going to release the next earnings report on Aug 13, 2024. Keep track of upcoming events with our Earnings Calendar.
ARDS net income for the last quarter is ‪−83.00 K‬ USD, while the quarter before that showed ‪12.14 M‬ USD of net income which accounts for −100.68% change. Track more Aridis Pharmaceuticals Inc. financial stats to get the full picture.
No, ARDS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 15, 2024, the company has 37.00 employees. See our rating of the largest employees — is Aridis Pharmaceuticals Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Aridis Pharmaceuticals Inc. EBITDA is ‪−574.00 K‬ USD, and current EBITDA margin is −954.58%. See more stats in Aridis Pharmaceuticals Inc. financial statements.
Like other stocks, ARDS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aridis Pharmaceuticals Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Aridis Pharmaceuticals Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Aridis Pharmaceuticals Inc. stock shows the sell signal. See more of Aridis Pharmaceuticals Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.